Antibody Information

General Information of This Antibody

Antibody ID	ANI0UBARP
Antibody Name	Humanized anti B7-H4 SGNB7H4V mAb
Synonyms	h1D11 Click to Show/Hide
Antibody Type	Monoclonal antibody (mAb)
Antibody Subtype	Humanized IgG1-kappa
Antigen Name	V-set domain-containing T-cell activation inhibitor 1 (VTCN1)	Antigen Info

Each Antibody-drug Conjugate Related to This Antibody

Full Information of The Activity Data of The ADC(s) Related to This Antibody

SGN-B7H4V [Phase 1]

ADC Info

Identified from the Human Clinical Data

Click To Hide/Show 1 Activity Data Related to This Level

Experiment 1 Reporting the Activity Date of This ADC				[1]
Patients Enrolled	Locally advanced unresectable or metastatic solid tumors.
*Related Clinical Trial*
NCT Number	NCT05194072	Clinical Status	Phase 1
Clinical Description	A phase 1 study of SGN-B7H4V in advanced solid tumors.

References

Ref 1	First-in-human phase I study of ALT-P7, a HER2-targeting antibody-drug conjugate in patients with HER2-positive advanced breast cancer. J Clin Oncol. 2020 38:15_suppl, 3551-3551.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.